These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 18415710
1. The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology. Ersoz S, Sert H, Yandi M, Erem C, Mungan S, Ersoz HO, Cobanoglu U, Hacihasanoglu A. Pathol Oncol Res; 2008 Dec; 14(4):457-60. PubMed ID: 18415710 [Abstract] [Full Text] [Related]
2. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas. Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F. J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548 [Abstract] [Full Text] [Related]
3. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules. Abd-El Raouf SM, Ibrahim TR. Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837 [Abstract] [Full Text] [Related]
4. Proteomic identification of new biomarkers and application in thyroid cytology. Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ. Acta Cytol; 2006 Dec; 50(5):518-28. PubMed ID: 17017437 [Abstract] [Full Text] [Related]
5. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules]. Wang LH, Zhao YJ, Wang XY, Yuan P, Xu WQ, Xiao JC, Xu JP, Luo BR. Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854 [Abstract] [Full Text] [Related]
6. The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions. Raggio E, Camandona M, Solerio D, Martino P, Franchello A, Orlandi F, Gasparri G. J Endocrinol Invest; 2010 Jun; 33(6):378-81. PubMed ID: 19625759 [Abstract] [Full Text] [Related]
7. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F, Papotti M. Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105 [Abstract] [Full Text] [Related]
8. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology. Bizzarro T, Martini M, Marrocco C, D'Amato D, Traini E, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM, Rossi ED. PLoS One; 2015 Jun; 10(7):e0132939. PubMed ID: 26186733 [Abstract] [Full Text] [Related]
9. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor]. Fang Q, Cai C, Chen H. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):668-72. PubMed ID: 26696207 [Abstract] [Full Text] [Related]
10. Contribution of immunocytochemical stainings for galectin-3, CD44, and HBME1 to fine-needle aspiration cytology diagnosis of papillary thyroid carcinoma. Das DK, Al-Waheeb SK, George SS, Haji BI, Mallik MK. Diagn Cytopathol; 2014 Jun; 42(6):498-505. PubMed ID: 24273003 [Abstract] [Full Text] [Related]
11. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. Collet JF, Hurbain I, Prengel C, Utzmann O, Scetbon F, Bernaudin JF, Fajac A. Br J Cancer; 2005 Nov 14; 93(10):1175-81. PubMed ID: 16251880 [Abstract] [Full Text] [Related]
12. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses]. Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP. Zhonghua Bing Li Xue Za Zhi; 2004 Jun 14; 33(3):212-6. PubMed ID: 15256110 [Abstract] [Full Text] [Related]
13. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma]. Ouyang D, Chen FJ, Wei MW, Yang AK, Chen ZQ, Li QL, Chen YF. Ai Zheng; 2005 Nov 14; 24(11):1367-71. PubMed ID: 16552965 [Abstract] [Full Text] [Related]
14. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor. Cui W, Lu X, Zheng S, Ma Y, Liu X, Zhang W. Clin Lab; 2012 Nov 14; 58(5-6):419-26. PubMed ID: 22783570 [Abstract] [Full Text] [Related]
15. Quantitative Analysis of Galectin-3 Expression in Benign and Malignant Thyroid Nodules. Šamija I, Mateša N, Tadinac S, Jukić T. Acta Clin Croat; 2020 Jun 14; 59(Suppl 1):25-31. PubMed ID: 34219881 [Abstract] [Full Text] [Related]
16. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T. Cancer; 1999 Jun 01; 85(11):2475-84. PubMed ID: 10357421 [Abstract] [Full Text] [Related]
17. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G. Acta Cytol; 2006 Jun 01; 50(1):28-34. PubMed ID: 16514837 [Abstract] [Full Text] [Related]
18. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N. Cancer Lett; 2005 Feb 28; 219(1):91-6. PubMed ID: 15694668 [Abstract] [Full Text] [Related]
19. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R. Pol J Pathol; 2003 Feb 28; 54(2):111-5. PubMed ID: 14575419 [Abstract] [Full Text] [Related]
20. Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions. Aiad HA, Kandil MA, Asaad NY, El-Kased AM, El-Goday SF. J Egypt Natl Canc Inst; 2008 Mar 28; 20(1):36-46. PubMed ID: 19847280 [Abstract] [Full Text] [Related] Page: [Next] [New Search]